Kk. Koeller et al., From the archives of the AFIP - Neoplasms of the spinal cord and filum terminale: Radiologic-pathologic correlation, RADIOGRAPHI, 20(6), 2000, pp. 1721-1749
Intramedullary spinal cord neoplasms are rare, accounting for about 4%-10%
of all central nervous system tumors. Despite their rarity, these lesions a
re important to the radiologist because magnetic resonance (MR) imaging is
the preoperative study of choice to narrow the differential diagnosis and g
uide surgical resection. On contrast material-enhanced MR images, intramedu
llary spinal tumors almost always manifest as expansion of the spinal cord
and show enhancement. Syringohydromyelia and cystic lesions are frequently
associated with intramedullary tumors. Nontumoral cysts tend to be located
at the poles of the tumors and do not enhance on contrast-enhanced MR image
s, whereas cysts within the substance of the tumor are considered tumoral c
ysts and typically demonstrate peripheral enhancement. Spinal cord ependymo
mas are the most common type in adults, and cord astrocytomas are most comm
on in children. Both entities constitute up to 70% of all intramedullary ne
oplasms. A central location within the spinal cord, presence of a cleavage
and intense homogeneous enhancement are imaging features that fa-plane, vor
an ependymoma. Intramedullary astrocytomas are usually eccentrically locat
ed within the cord, are ill defined, and have patchy enhancement after intr
avenous contrast material administration. Even with these characteristics,
it may not be possible to differentiate these two entities on the basis of
imaging features alone. Cord hemangioblastomas are the third most common ty
pe of intramedullary spinal tumor. Gangliogliomas commonly extend over more
than eight vertebral segments. Paragangliomas and primitive neuroectoderma
l tumors have an affinity for the filum terminale and cauda equina. Other s
pinal cord tumors include metastatic disease, which is characterized by pro
minent cord edema for the size of the enhancing portion, and primary lympho
ma.